FT: AstraZeneca and Bristol-Myers Squibb plan $400bn merger
AI Summary
Despite months-long discussions, talks could still fall apart, reports the Financial Times. Read more: FT: AstraZeneca and Bristol-Myers Squibb plan $400bn merger
Discussion
Sign in to join the discussion.
Loading comments…